Do analysts rate DXR or ADGM?

Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 378.14%. Given Adagio Medical's higher probable upside, analysts plainly believe Adagio Medical is more favorable than Daxor. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger earnings and valuation, DXR or ADGM?

Daxor has higher revenue and earnings than Adagio Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Daxor $10.30M 5.89 N/A N/A N/A Adagio Medical N/A N/A -$25.08M -$1.53 N/A

Is DXR or ADGM more profitable?

Daxor's return on equity of 0.00% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Daxor N/A N/A N/A Adagio Medical N/A -382.50% -64.98%

Does the media favor DXR or ADGM?

In the previous week, Adagio Medical had 3 more articles in the media than Daxor. MarketBeat recorded 4 mentions for Adagio Medical and 1 mentions for Daxor. Daxor's average media sentiment score of 0.67 beat Adagio Medical's score of 0.33 indicating that Daxor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daxor 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adagio Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer ECOR or ADGM?

In the previous week, electroCore and electroCore both had 4 articles in the media. electroCore's average media sentiment score of 0.49 beat Adagio Medical's score of 0.33 indicating that electroCore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Adagio Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is ADGM or NYXH more profitable?

Adagio Medical has a net margin of 0.00% compared to Nyxoah's net margin of -543.21%. Nyxoah's return on equity of -163.73% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Adagio Medical N/A -382.50% -64.98% Nyxoah -543.21% -163.73% -80.24%

Does the media prefer ADGM or NYXH?

In the previous week, Nyxoah had 3 more articles in the media than Adagio Medical. MarketBeat recorded 7 mentions for Nyxoah and 4 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.33 beat Nyxoah's score of -0.20 indicating that Adagio Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nyxoah 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor ADGM or MDAI?

In the previous week, Adagio Medical had 2 more articles in the media than Spectral AI. MarketBeat recorded 4 mentions for Adagio Medical and 2 mentions for Spectral AI. Spectral AI's average media sentiment score of 1.04 beat Adagio Medical's score of 0.33 indicating that Spectral AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Spectral AI 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Adagio Medical (ADGM) Competitors

$0.73 -0.01 (-0.95%)

Closing price 04:00 PM Eastern

Extended Trading

$0.72 -0.01 (-1.91%)

As of 05:13 PM Eastern

Compare

ADGM vs. DXR, ECOR, NYXH, COCH, and MDAI

Should you buy Adagio Medical stock or one of its competitors? MarketBeat compares Adagio Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Adagio Medical include Daxor (DXR), electroCore (ECOR), Nyxoah (NYXH), Envoy Medical (COCH), and Spectral AI (MDAI). These companies are all part of the "healthcare equipment" industry.

How does Adagio Medical compare to Daxor?

Daxor (NASDAQ:DXR) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Adagio Medical has a consensus target price of $3.50, indicating a potential upside of 378.14%. Given Adagio Medical's higher probable upside, analysts plainly believe Adagio Medical is more favorable than Daxor.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Daxor has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.15, suggesting that its share price is 115% less volatile than the broader market.

In the previous week, Adagio Medical had 3 more articles in the media than Daxor. MarketBeat recorded 4 mentions for Adagio Medical and 1 mentions for Daxor. Daxor's average media sentiment score of 0.67 beat Adagio Medical's score of 0.33 indicating that Daxor is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Daxor	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Adagio Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Daxor has higher revenue and earnings than Adagio Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	$10.30M	5.89	N/A	N/A	N/A
Adagio Medical	N/A	N/A	-$25.08M	-$1.53	N/A

Daxor's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Adagio Medical	N/A	-382.50%	-64.98%

1.3% of Daxor shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 51.5% of Daxor shares are held by company insiders. Comparatively, 7.8% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Daxor beats Adagio Medical on 7 of the 11 factors compared between the two stocks.

How does Adagio Medical compare to electroCore?

electroCore (NASDAQ:ECOR) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

26.7% of electroCore shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 7.8% of electroCore shares are held by insiders. Comparatively, 7.8% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

electroCore presently has a consensus price target of $18.00, suggesting a potential upside of 168.66%. Adagio Medical has a consensus price target of $3.50, suggesting a potential upside of 378.14%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

electroCore has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.15, meaning that its stock price is 115% less volatile than the broader market.

In the previous week, electroCore and electroCore both had 4 articles in the media. electroCore's average media sentiment score of 0.49 beat Adagio Medical's score of 0.33 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Adagio Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

electroCore has higher revenue and earnings than Adagio Medical. electroCore is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$34.90M	1.73	-$13.97M	-$1.77	N/A
Adagio Medical	N/A	N/A	-$25.08M	-$1.53	N/A

Adagio Medical has a net margin of 0.00% compared to electroCore's net margin of -44.08%. Adagio Medical's return on equity of -382.50% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-44.08%	-1,956.38%	-83.30%
Adagio Medical	N/A	-382.50%	-64.98%

Summary

Adagio Medical beats electroCore on 10 of the 14 factors compared between the two stocks.

How does Adagio Medical compare to Nyxoah?

Adagio Medical (NASDAQ:ADGM) and Nyxoah (NASDAQ:NYXH) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

Adagio Medical has a net margin of 0.00% compared to Nyxoah's net margin of -543.21%. Nyxoah's return on equity of -163.73% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-382.50%	-64.98%
Nyxoah	-543.21%	-163.73%	-80.24%

Adagio Medical presently has a consensus target price of $3.50, suggesting a potential upside of 378.14%. Nyxoah has a consensus target price of $5.26, suggesting a potential upside of 301.68%. Given Adagio Medical's higher probable upside, equities analysts clearly believe Adagio Medical is more favorable than Nyxoah.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Adagio Medical has higher earnings, but lower revenue than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	N/A	N/A	-$25.08M	-$1.53	N/A
Nyxoah	$15.33M	3.31	-$101.92M	-$2.52	N/A

48.1% of Adagio Medical shares are held by institutional investors. 7.8% of Adagio Medical shares are held by company insiders. Comparatively, 17.1% of Nyxoah shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Adagio Medical has a beta of -0.15, indicating that its share price is 115% less volatile than the broader market. Comparatively, Nyxoah has a beta of 1.62, indicating that its share price is 62% more volatile than the broader market.

In the previous week, Nyxoah had 3 more articles in the media than Adagio Medical. MarketBeat recorded 7 mentions for Nyxoah and 4 mentions for Adagio Medical. Adagio Medical's average media sentiment score of 0.33 beat Nyxoah's score of -0.20 indicating that Adagio Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nyxoah	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Adagio Medical beats Nyxoah on 8 of the 13 factors compared between the two stocks.

How does Adagio Medical compare to Envoy Medical?

Adagio Medical (NASDAQ:ADGM) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Adagio Medical presently has a consensus target price of $3.50, indicating a potential upside of 378.14%. Envoy Medical has a consensus target price of $2.25, indicating a potential upside of 230.49%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical is more favorable than Envoy Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Adagio Medical has a beta of -0.15, meaning that its share price is 115% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.9, meaning that its share price is 90% more volatile than the broader market.

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 7.8% of Adagio Medical shares are held by insiders. Comparatively, 7.1% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Adagio Medical had 4 more articles in the media than Envoy Medical. MarketBeat recorded 4 mentions for Adagio Medical and 0 mentions for Envoy Medical. Adagio Medical's average media sentiment score of 0.33 beat Envoy Medical's score of 0.00 indicating that Adagio Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Adagio Medical	Neutral
Envoy Medical	Neutral

Envoy Medical has higher revenue and earnings than Adagio Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	N/A	N/A	-$25.08M	-$1.53	N/A
Envoy Medical	$234K	223.68	-$23.76M	-$1.01	N/A

Adagio Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-382.50%	-64.98%
Envoy Medical	-9,875.64%	N/A	-177.92%

Summary

Adagio Medical beats Envoy Medical on 10 of the 15 factors compared between the two stocks.

How does Adagio Medical compare to Spectral AI?

Adagio Medical (NASDAQ:ADGM) and Spectral AI (NASDAQ:MDAI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 7.8% of Adagio Medical shares are held by insiders. Comparatively, 13.7% of Spectral AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Spectral AI has higher revenue and earnings than Adagio Medical. Spectral AI is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	N/A	N/A	-$25.08M	-$1.53	N/A
Spectral AI	$19.65M	2.69	-$7.57M	-$0.53	N/A

Adagio Medical presently has a consensus target price of $3.50, indicating a potential upside of 378.14%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 140.96%. Given Adagio Medical's higher probable upside, equities analysts plainly believe Adagio Medical is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Adagio Medical has a net margin of 0.00% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-382.50%	-64.98%
Spectral AI	-85.58%	N/A	-72.97%

Adagio Medical has a beta of -0.15, indicating that its share price is 115% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

In the previous week, Adagio Medical had 2 more articles in the media than Spectral AI. MarketBeat recorded 4 mentions for Adagio Medical and 2 mentions for Spectral AI. Spectral AI's average media sentiment score of 1.04 beat Adagio Medical's score of 0.33 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Spectral AI	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Spectral AI beats Adagio Medical on 10 of the 16 factors compared between the two stocks.

Get Adagio Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADGM vs. The Competition

Export

Metric	Adagio Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$16.26M	$5.72B	$6.93B	$12.84B
Dividend Yield	N/A	1.78%	2.60%	9.78%
P/E Ratio	-0.48	24.74	281.16	25.43
Price / Sales	N/A	59.08	575.77	80.37
Price / Cash	N/A	32.67	71.79	50.79
Price / Book	1.24	6.02	12.86	6.06
Net Income	-$25.08M	$152.55M	$3.49B	$348.34M
7 Day Performance	95.46%	3.36%	2.63%	3.03%
1 Month Performance	16.93%	-1.73%	-2.64%	-3.04%
1 Year Performance	-46.18%	8.89%	76.00%	20.65%

Adagio Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADGM Adagio Medical	2.133 of 5 stars	$0.73 -0.9%	$3.50 +378.1%	-43.2%	$16.26M	N/A	N/A	87	Upcoming Earnings
DXR Daxor	1.3763 of 5 stars	$10.18 -3.2%	N/A	+2.1%	$59.45M	N/A	N/A	37
ECOR electroCore	2.5981 of 5 stars	$6.36 +2.0%	$18.00 +183.2%	-4.8%	$56.96M	$32.03M	N/A	50	Gap Down
NYXH Nyxoah	2.9008 of 5 stars	$1.42 -2.1%	$5.96 +319.9%	-81.1%	$54.85M	$11.33M	N/A	110	News Coverage Earnings Report Analyst Forecast Gap Down
COCH Envoy Medical	2.391 of 5 stars	$0.70 +1.0%	$2.25 +223.7%	-53.8%	$53.43M	$240K	N/A	34

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADGM) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adagio Medical (ADGM) Competitors

ADGM vs. DXR, ECOR, NYXH, COCH, and MDAI

How does Adagio Medical compare to Daxor?

Summary

How does Adagio Medical compare to electroCore?

Summary

How does Adagio Medical compare to Nyxoah?

Summary

How does Adagio Medical compare to Envoy Medical?

Summary

How does Adagio Medical compare to Spectral AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adagio Medical (ADGM) Competitors

ADGM vs. DXR, ECOR, NYXH, COCH, and MDAI

How does Adagio Medical compare to Daxor?

Do analysts rate DXR or ADGM?

Which has more risk & volatility, DXR or ADGM?

Does the media favor DXR or ADGM?

Which has stronger earnings and valuation, DXR or ADGM?

Is DXR or ADGM more profitable?

Do institutionals and insiders have more ownership in DXR or ADGM?

Summary

How does Adagio Medical compare to electroCore?

Do insiders & institutionals hold more shares of ECOR or ADGM?

Do analysts prefer ECOR or ADGM?

Which has more risk & volatility, ECOR or ADGM?

Does the media prefer ECOR or ADGM?

Which has stronger earnings & valuation, ECOR or ADGM?

Is ECOR or ADGM more profitable?

Summary

How does Adagio Medical compare to Nyxoah?

Is ADGM or NYXH more profitable?

Do analysts recommend ADGM or NYXH?

Which has better earnings and valuation, ADGM or NYXH?

Do institutionals and insiders have more ownership in ADGM or NYXH?

Which has more risk & volatility, ADGM or NYXH?

Does the media prefer ADGM or NYXH?

Summary

How does Adagio Medical compare to Envoy Medical?

Do analysts recommend ADGM or COCH?

Which has more risk and volatility, ADGM or COCH?

Do institutionals & insiders have more ownership in ADGM or COCH?

Does the media favor ADGM or COCH?

Which has stronger valuation and earnings, ADGM or COCH?

Is ADGM or COCH more profitable?

Summary

How does Adagio Medical compare to Spectral AI?

Do institutionals & insiders believe in ADGM or MDAI?

Which has better valuation and earnings, ADGM or MDAI?

Do analysts rate ADGM or MDAI?

Is ADGM or MDAI more profitable?

Which has more risk and volatility, ADGM or MDAI?

Does the media favor ADGM or MDAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADGM vs. The Competition

Adagio Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools